10.6084/m9.figshare.5798352.v1 Sarah Biedermann Sarah Biedermann Daniel Biedermann Daniel Biedermann Frederike Wenzlaff Frederike Wenzlaff Tim Kurjak Tim Kurjak Sawis Nouri Sawis Nouri Matthias Auer Matthias Auer Klaus Wiedemann Klaus Wiedemann Peer Briken Peer Briken Jan Haaker Jan Haaker Tina Lonsdorf Tina Lonsdorf Johannes Fuss Johannes Fuss Additional file 9: Table S7. of An elevated plus-maze in mixed reality for studying human anxiety-related behavior Springer Nature 2017 Virtual reality Approach Avoidance Risk assessment Behavioral assay Anxiety disorder Acrophobia Sensation seeking Yohimbine Lorazepam 2017-12-21 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_9_Table_S7_of_An_elevated_plus-maze_in_mixed_reality_for_studying_human_anxiety-related_behavior/5798352 Side effects after medication in Study 2. Data were collected directly before behavioral testing (i.e., 55 min after medication). (DOCX 19 kb)